Kelly E Gill1, Jean M Quintero2, S Lucy Poe2, Alvaro D Moreira2, Gary Brucato2, Cheryl M Corcoran2, Ragy R Girgis2. 1. Department of Psychiatry at Columbia University Medical Center, New York, NY, United States; Department of Psychology at The Catholic University of America, Washington, DC, United States. Electronic address: kegill13@gmail.com. 2. Department of Psychiatry at Columbia University Medical Center, New York, NY, United States.
Abstract
BACKGROUND: The majority of individuals with schizophrenia and other psychotic illnesses have had suicidal ideation at some point during the illness. However, little is known about the variation in level and intensity of suicidal ideation and symptoms in the attenuated stage of psychotic illness. Our aims were to assess prevalence of suicidal ideation in this at risk group, and to examine the severity and intensity of suicidal ideation, and their relation to symptoms. METHODS: Suicidal ideation was assessed in 42 clinical high-risk participants using the Columbia Suicide Severity Rating Scale (C-SSRS). We hypothesized that prevalence rates would be similar to what was found in previous studies, and individuals with suicidal ideation would have higher positive and negative symptoms, with poorer functioning. We assessed levels of severity and intensity of suicidal ideation related to these symptoms, and examined how depressive symptoms affected these relationships. RESULTS: Nearly half (42.9%) of participants reported having current suicidal ideation. We found no relationship to positive symptoms. However, severity and intensity of suicidal ideation were found to be related to negative symptoms and level of functioning. When controlling for depressive symptoms during exploratory analysis, this relationship still emerged. CONCLUSIONS: This study adds to the literature demonstrating the complex nature of suicidal ideation in psychotic illness. The C-SSRS has shown to be helpful in determining relationships between severity and intensity in suicidal ideation in relation to specific symptoms in a research setting. Published by Elsevier B.V.
BACKGROUND: The majority of individuals with schizophrenia and other psychotic illnesses have had suicidal ideation at some point during the illness. However, little is known about the variation in level and intensity of suicidal ideation and symptoms in the attenuated stage of psychotic illness. Our aims were to assess prevalence of suicidal ideation in this at risk group, and to examine the severity and intensity of suicidal ideation, and their relation to symptoms. METHODS: Suicidal ideation was assessed in 42 clinical high-risk participants using the Columbia Suicide Severity Rating Scale (C-SSRS). We hypothesized that prevalence rates would be similar to what was found in previous studies, and individuals with suicidal ideation would have higher positive and negative symptoms, with poorer functioning. We assessed levels of severity and intensity of suicidal ideation related to these symptoms, and examined how depressive symptoms affected these relationships. RESULTS: Nearly half (42.9%) of participants reported having current suicidal ideation. We found no relationship to positive symptoms. However, severity and intensity of suicidal ideation were found to be related to negative symptoms and level of functioning. When controlling for depressive symptoms during exploratory analysis, this relationship still emerged. CONCLUSIONS: This study adds to the literature demonstrating the complex nature of suicidal ideation in psychotic illness. The C-SSRS has shown to be helpful in determining relationships between severity and intensity in suicidal ideation in relation to specific symptoms in a research setting. Published by Elsevier B.V.
Entities:
Keywords:
Clinical high risk; Functioning; Psychosis; Schizophrenia; Suicidal ideation
Authors: Tandy J Miller; Thomas H McGlashan; Joanna L Rosen; Kristen Cadenhead; Tyrone Cannon; Joseph Ventura; William McFarlane; Diana O Perkins; Godfrey D Pearlson; Scott W Woods Journal: Schizophr Bull Date: 2003 Impact factor: 9.306
Authors: Peter James Taylor; Patricia A Gooding; Alex M Wood; Judith Johnson; Daniel Pratt; Nicholas Tarrier Journal: Psychiatry Res Date: 2010-05-15 Impact factor: 3.222
Authors: C M Corcoran; D Kimhy; M A Parrilla-Escobar; V L Cressman; A D Stanford; J Thompson; S Ben David; A Crumbley; S Schobel; H Moore; D Malaspina Journal: Psychol Med Date: 2010-05-06 Impact factor: 7.723
Authors: Margaux M Grivel; Wei Leong; Michael D Masucci; Rebecca A Altschuler; Leigh Y Arndt; Samantha L Redman; Lawrence H Yang; Gary Brucato; Ragy R Girgis Journal: Schizophr Res Date: 2017-09-19 Impact factor: 4.939
Authors: Elizabeth Thompson; Anthony Spirito; Elisabeth Frazier; Alysha Thompson; Jeffrey Hunt; Jennifer Wolff Journal: Schizophr Res Date: 2020-01-13 Impact factor: 4.939
Authors: Lindsay A Bornheimer; Jessica A Wojtalik; Juliann Li; Derin Cobia; Matthew J Smith Journal: Schizophr Res Date: 2021-01-23 Impact factor: 4.939
Authors: Ragy R Girgis; Rakshathi Basavaraju; Jeanelle France; Melanie M Wall; Gary Brucato; Jeffrey A Lieberman; Frank A Provenzano Journal: Psychiatry Res Neuroimaging Date: 2021-04-07 Impact factor: 2.493
Authors: Miriam Sánchez SanSegundo; Rosario Ferrer-Cascales; Jesús H Bellido; Mar P Bravo; Javier Oltra-Cucarella; Harry G Kennedy Journal: Front Psychol Date: 2018-08-07
Authors: Juan F Rodríguez-Testal; Salvador Perona-Garcelán; Sonia Dollfus; María Valdés-Díaz; Jesús García-Martínez; Miguel Ruíz-Veguilla; Cristina Senín-Calderón Journal: BMC Psychiatry Date: 2019-10-29 Impact factor: 3.630